The cost of a viral contamination event can be as much as $100 million due to lost sales and product, in addition to shortage of drug supply to patients.
A new, more rapid but still broad, sensitive detection of virus method to use in viral vaccine production.
General test for viral infectivity in cultured cells without requiring the use of specific probes
Reduce the amount of time required by an assay to detect virus in cultured cells thus lowering the cost of a contamination event and resulting in less drug supply lost
Cultured cells analyzed for infectivity in real time (hundreds of cells analyzed in less than 5 minutes)
McCracken, R., Al-Nazal, N., Whitmer, T., Yi, S., Wagner, J. M., Hebert, C. G., Lowry, M. J., Hayes, P. R., Schneider, J. W., Przybycien, T. M., & Mukherjee, M. (2022). Rapid In-Process Measurement of Live Virus Vaccine Potency Using Laser Force Cytology: Paving the Way for Rapid Vaccine Development. Vaccines, 10(10). https://doi.org/10.3390/vaccines10101589
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Carnegie Mellon University
LumaCyte
Merck Sharp & Dohme LLC
Rensselaer Polytechnic Institute